As an increase in cAMP levels is associated with an increase in cytosolic free calcium and this triggers the GH secretion, it is probably that genetic and/or epigenetic alterations in these pathways lead to the development of somatotropinomas. This evidence concerns the gene GH1 and growth hormone-producing pituitary gland neoplasm.